Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d667d655d078f7fd940f008043ccc62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44069c4167142ef8ba39f48c767487d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89789fae8201f9e31eb4e63df676ddf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48fe53d6041a793bf6f56fc6b3c6ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1b4feba286243391c21affd691d7484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbaed59187e8ebdeb1fbc7086567b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_186ab984c2b4dbf5227066711df2b4a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f518dc5b1096d070c21e8ce387e411ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ebad5772e2092ebae13826a99fcf9f |
publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015034169-A1 |
titleOfInvention |
Pharmaceutical composition containing 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or a pharmaceutically acceptable salt thereof as active ingredient for preventing or treating diabetes |
abstract |
The present invention relates to a pharmaceutical composition and functional health food containing 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating diabetes. The 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or the pharmaceutically acceptable salt thereof according to the present invention can be effectively used to treat diabetes including type 1 diabetes and type 2 diabetes, and the compound can be used as a functional health food for preventing or ameliorating diabetes. |
priorityDate |
2013-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |